Stockscreener 앱 받기
0.00
100.00%
-9.71
시간 외 거래:
9.75
9.75
+
전일 마감가:
$9.71
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$39.28M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
0.00
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$12.60
Fibrogen Inc Stock (FGEN) Company Profile
명칭
Fibrogen Inc
전화
415-978-1200
주소
350 BAY STREET, SAN FRANCISCO, CA
Compare FGEN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
0.00 | 39.28M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-26 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-06-26 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | 업그레이드 | Stifel | Hold → Buy |
| 2023-01-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-09-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-20 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-07-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-03-31 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-01 | 개시 | H.C. Wainwright | Buy |
| 2020-10-26 | 개시 | Raymond James | Underperform |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2020-05-01 | 개시 | Cowen | Market Perform |
| 2020-04-27 | 개시 | BofA/Merrill | Neutral |
| 2019-05-29 | 재개 | Goldman | Neutral |
| 2019-05-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | 개시 | Piper Jaffray | Neutral |
| 2019-02-11 | 재개 | Stifel | Buy |
| 2018-12-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-08-08 | 재확인 | Leerink Partners | Outperform |
| 2017-08-08 | 재확인 | Stifel | Buy |
| 2017-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2016-02-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Neutral |
| 2015-12-04 | 개시 | Citigroup | Buy |
| 2015-09-23 | 개시 | Lake Street | Hold |
| 2015-07-29 | 개시 | Citigroup | Buy |
| 2015-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2014-12-09 | 개시 | Stifel | Buy |
모두보기
Fibrogen Inc 주식(FGEN)의 최신 뉴스
FGEN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Breakouts: Can FibroGen Inc be the next market leaderJuly 2025 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
Returns Recap: What is the target price for FibroGen Inc stockTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn
What's Going On With Kyntra Bio Stock Tuesday? - Bitget
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 - marketscreener.com
Earnings Risk: Is FibroGen Inc stock a value trapWeekly Stock Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
FibroGen (FGEN) Delisted: What’s Really Left for Shareholders? - AD HOC NEWS
Analyst Upgrade: Why is FibroGen Inc stock going up2025 Performance Recap & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Trading Recap: Is FibroGen Inc stock a value trap2025 Valuation Update & Precise Trade Entry Recommendations - baoquankhu1.vn
Kyntra Bio to Participate in Upcoming Investor Conferences - The Manila Times
Sentiment Recap: Is FibroGen Inc stock heavily shorted2025 Historical Comparison & Weekly Watchlist of Top Performers - baoquankhu1.vn
Support Test: Will FibroGen Inc. benefit from rising consumer demandPortfolio Gains Summary & High Accuracy Buy Signal Tips - mfd.ru
Can FibroGen Inc. sustain its profitabilityEarnings Trend Report & Reliable Price Breakout Alerts - mfd.ru
Aug Volume: Will Global Indemnity Group LLC Preferred Security benefit from geopolitical trendsVolume Spike & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is FibroGen Inc. stock a top pick in earnings seasonLong Setup & Daily Technical Forecast Reports - mfd.ru
Jobs Data: Is FibroGen Inc stock a buy or sellEarnings Summary Report & Accurate Trade Setup Notifications - baoquankhu1.vn
KYNB SEC FilingsKYNTRA BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Movers: Will FibroGen Inc benefit from AI trends2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
Sentiment Review: Will FibroGen Inc benefit from AI trendsWeekly Market Report & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Quarterly Risk: Will FibroGen Inc benefit from AI trends2025 Retail Activity & Smart Allocation Stock Tips - baoquankhu1.vn
Price Action: Can FibroGen Inc be the next market leader2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Kyntra Bio (KYNB) Stock Price, News & Analysis - MarketBeat
Aug Technicals: Will FibroGen Inc stock benefit from M AWeekly Market Outlook & Community Trade Idea Sharing - baoquankhu1.vn
Jobs Data: Will FibroGen Inc. stock outperform international peers2025 Winners & Losers & Safe Capital Growth Tips - Bộ Nội Vụ
Sentiment Review: Will FibroGen Inc benefit from government policyMarket Trend Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aug Sentiment: Is FibroGen Inc. stock heavily shorted2025 Market Outlook & Weekly Watchlist of Top Performers - baoquankhu1.vn
RSI Check: Why FibroGen Inc stock remains on buy listsShort Setup & Reliable Intraday Trade Alerts - Bộ Nội Vụ
How FibroGen Inc. stock reacts to inflationary pressuresJuly 2025 Drop Watch & Risk Managed Investment Signals - Улправда
KYNB: Kyntra Bio IncFull Company Report - Zacks Investment Research
Trend Recap: Why FibroGen Inc. stock is a must watch in 2025Trade Signal Summary & Technical Confirmation Trade Alerts - ulpravda.ru
Why FibroGen Inc. stock is a must watch in 2025Market Growth Report & Fast Exit and Entry Trade Guides - Улправда
Aug Chart Watch: Is FibroGen Inc. stock undervalued vs historical averagesJuly 2025 Intraday Action & Weekly High Return Stock Forecasts - Улправда
Published on: 2026-01-09 00:07:25 - Улправда
Is FibroGen Inc. stock a buy before product launches2025 Trading Recap & AI Based Trade Execution Alerts - Улправда
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum - MarketScreener
FibroGen (FGEN) Faces Option Delistings as of January 8th - GuruFocus
One new option listing and one option delisting on January 8th - TipRanks
FibroGen rebrands as Kyntra Bio with new Nasdaq ticker KYNB By Investing.com - Investing.com Nigeria
FibroGen nabs ex-Lilly Conterno as CEO - The Pharma Letter
FibroGen (FGEN) Transforms into Kyntra Bio with a New Focus - GuruFocus
FibroGen stock rises after announcing rebrand to Kyntra Bio By Investing.com - Investing.com South Africa
FibroGen stock rises after announcing rebrand to Kyntra Bio - Investing.com
FibroGen rebrands as Kyntra Bio with new Nasdaq ticker KYNB - Investing.com
FibroGen, Inc. Rebrands to Kyntra Bio, Targeting Oncology and Rare Disease Therapeutics with New Nasdaq Trading Symbol "KYNB" - Quiver Quantitative
FibroGen rebrands to Kyntra Bio - marketscreener.com
Quarterly Earnings: Is FibroGen Inc stock a buy before product launchesJuly 2025 Review & Weekly Momentum Picks - moha.gov.vn
FibroGen shares advance after roxadustat earns orphan drug status - MSN
Fibrogen Inc (FGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):